公开(公告)号：US20200087730A1

公开(公告)日：2020-03-19

申请号：US16469820

申请日：2017-12-14

Applicant: DREXEL UNIVERSITY ,  CONTEXT THERAPEUTICS

Inventor： Felix KIM ,  Halley OYER ,  John VAILLANCOURT

IPC: C12Q1/6886 ,  A61P35/00 ,  A61K31/155 ,  G16H50/20 ,  G16B40/10 ,  A61K31/4745

Abstract: Methods and uses of using Sigma1 inhibitors are provide herein, including diagnostic methods for predicting or identifying quantitatively whether a human tumor is responsive or non-responsive to treatment with Sigma1 inhibition are also provided.

公开(公告)号：US20240254561A1

公开(公告)日：2024-08-01

申请号：US18527076

申请日：2023-12-01

Applicant: Drexel University ,  Context Therapeutics

Inventor： Felix J. Kim ,  Halley Oyer ,  John Vaillancourt

IPC: C12Q1/6886 ,  A61K31/155 ,  A61K31/4745 ,  A61K45/06 ,  A61P35/00 ,  G16B40/10 ,  G16H50/20

CPC classification number: C12Q1/6886 ,  A61K31/155 ,  A61K31/4745 ,  A61P35/00 ,  G16B40/10 ,  G16H50/20 ,  A61K45/06

Abstract: Methods and uses of using Sigma1 inhibitors are provide herein, including diagnostic methods for predicting or identifying quantitatively whether a human tumor is responsive or non-responsive to treatment with Sigma1 inhibition are also provided.